Eden Research (LON:EDEN) Shares Down 13.2% – Here’s What Happened

Eden Research plc (LON:EDEN)’s stock price dropped 13.2% on Tuesday . The company traded as low as GBX 2.26 ($0.03) and last traded at GBX 2.37 ($0.03). Approximately 1,775,147 shares changed hands during trading, an increase of 133% from the average daily volume of 762,776 shares. The stock had previously closed at GBX 2.73 ($0.04).

Eden Research Stock Performance

The stock has a market cap of £13.87 million, a price-to-earnings ratio of -9.11 and a beta of 0.92. The company’s 50-day simple moving average is GBX 3.34 and its 200-day simple moving average is GBX 3.70. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling

In other news, insider Alexander John Abrey bought 167,947 shares of the firm’s stock in a transaction on Tuesday, March 4th. The stock was bought at an average cost of GBX 3 ($0.04) per share, for a total transaction of £5,038.41 ($6,542.54). Also, insider Sean M. Smith bought 426,986 shares of the company’s stock in a transaction dated Tuesday, April 1st. The stock was purchased at an average cost of GBX 234 ($3.04) per share, for a total transaction of £999,147.24 ($1,297,425.32). Insiders have purchased 1,391,473 shares of company stock worth $103,604,725 in the last three months. 14.02% of the stock is currently owned by insiders.

About Eden Research

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.